US CDMO Operations Update

Summary by AI BETAClose X

Abingdon Health PLC announced an update on its US CDMO operations, revealing that five new development projects are underway since the opening of Abingdon Health USA Inc facilities in April 2025. These projects, run from the Madison facility with support from the UK, include developing lateral flow tests for pharmaceutical, veterinary, and infectious disease applications. Furthermore, the company is progressing with phase two expansion plans for high throughput manufacturing capacity at the US facility. This expansion aims to mirror the UK operation, providing customers with manufacturing options in both the USA and the UK.

Disclaimer*

UK 100

Latest directors dealings